George Cire, Chris James, and Paula Greenham review the major treatment modalities, the general indications for implant use and referral, and present a picture of current clinical practice as reflected in Cochlear Ltd’s Implant Recipient Observational Study (IROS).
As a mechanic for more than 14 years, Tony uses power and impact tools that generate considerable noise. His hearing was gradually affected though he did not realize.Read More
A three-year-old is the first child in the United States to undergo an auditory brainstem implant surgery in an FDA-approved trial supported by a National Institutes of Health clinical trial grant.Read More
Results suggest that 6-month-old infants need less distortion and more frequency information than older children and adults to discriminate speech.Read More
The FDA has approved the Nucleus Hybrid L24 Cochlear Implant System for people 18 and older with severe or profound sensorineural hearing loss of high-frequency sounds in both ears, but who can still hear low-frequency sounds with or without a hearing aid.Read More